JP Morgan Chase
SPRB

JP Morgan Chase’s Spruce Biosciences SPRB Stock Holding History

JP Morgan Chase’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$19 – 7848
2025
Q1 		$19 Hold
1
– – ﹤0.01% 7135
2024
Q4 		$29 Hold
1
– – ﹤0.01% 7223
2024
Q3 		$33 Hold
1
– – ﹤0.01% 7184
2024
Q2 		$38 Buy
+1
New +$54 ﹤0.01% 7072
2024
Q1 		– Hold
0
– – – 7244
2023
Q4 		– Hold
0
– – – 7272
2023
Q3 		– Sell
-314
Closed -$52.9K – 7128
2023
Q2 		$50.7K Sell
314
-462
-60% -$77.2K ﹤0.01% 5717
2023
Q1 		$129K Buy
+776
New +$144K ﹤0.01% 5316
2022
Q4 		– Hold
0
– – – 7081
2022
Q3 		– Hold
0
– – – 6931
2022
Q2 		– Sell
-1,512
Closed -$194K – 6966
2022
Q1 		$227K Sell
1,512
-66
-4% -$12.3K ﹤0.01% 5125
2021
Q4 		$528K Sell
1,578
-95
-6% -$28.3K ﹤0.01% 4791
2021
Q3 		$754K Sell
1,673
-512
-23% -$321K ﹤0.01% 4493
2021
Q2 		$1.84M Sell
2,185
-215
-9% -$229K ﹤0.01% 3852
2021
Q1 		$2.99M Sell
2,400
-118
-5% -$181K ﹤0.01% 3400
2020
Q4 		$4.59M Buy
+2,518
New +$4.17M ﹤0.01% 2882

Other funds holding SPRB

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return

JP Morgan Chase's SPRB Position: Q2 2025 in Review

JP Morgan Chase sold out of Spruce Biosciences (SPRB) in Q2 2025, closing a stake of 1 share — an estimated $19 sold.

JP Morgan Chase first reported a position in SPRB in Q4 2020 and held it in 12 quarters. The position peaked at $4.59M in Q4 2020. 3 funds tracked by Wall St. Rank hold SPRB as of Q2 2025.

  • JP Morgan Chase reported no remaining Spruce Biosciences position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 1 Spruce Biosciences share in Q2 2025, an estimated $19.
  • JP Morgan Chase first reported a position in Spruce Biosciences in Q4 2020 and held it in 12 quarters.
  • JP Morgan Chase's Spruce Biosciences position peaked at $4.59M in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.